Schedule of Pharmaceutical Benefits - 1 July 2022

1 July 2022 - The July 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

FTC goes after PBMs, warns of legal action

2 July 2022 - Last month, the Federal Trade Commission voted unanimously (5-0) to examine rising list prices of insulin, but ...

Read more →

A key precedent may sustain negotiation to keep down Medicare drug prices

1 July 2022 - Medicare drug price negotiation, which holds down prices, may emerge from the long-quiet Senate negotiations on an ...

Read more →

Drug prices make headlines again as Senate Democrats push forward pricing reforms

1 July 2022 - Senate Democrats appear to be making progress on pushing forward a set of politically popular drug pricing ...

Read more →

Rare blood cancer drug Brukinsa to be listed for the first time on Pharmaceutical Benefits Scheme

1 July 2022 - Graeme Anderson had just finished seven days of night shift when he first noticed something didn’t feel ...

Read more →

NHS saves £1.2 billion on medicines over three years

1 July 2022 - The NHS has saved taxpayers £1.2 billion in just three years, while securing cutting-edge treatments for ...

Read more →

Public Summary Documents – March 2022 PBAC meeting

1 July 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2022 PBAC ...

Read more →

US FDA seeks more information on Maxigesic IV application

1 July 2022 - Hyloris Pharmaceuticals announces that it has today received a complete response letter from the US FDA on ...

Read more →

New PBS listings from 1 July 2022

1 July 2022 - Vitrakvi (larotrectinib) will list for the first time for the treatment of adult and paediatric patients with ...

Read more →

COVID-19 vaccine safety report (30 June 2022)

30 June 2022 - The Australian Government has decided the COVID-19 vaccine safety report will now be published fortnightly instead of ...

Read more →

Australian Medical Association prescribes new regulator to save private health system

30 June 2022 - The Australian Medical Association is calling for a new regulator to oversee the private health system, ...

Read more →

PBS listing for ‘Australian success story’ blood cancer drug

1 July 2022 - A pill that removes the need for chemotherapy for some cancer sufferers has been put on ...

Read more →

New strategic agreements with the medicines industry – PBS website updates

1 July 2022 - Amendments made by the National Health Amendment (Enhancing the Pharmaceutical Benefits Scheme) Act 2021 give effect to ...

Read more →

Aura Biosciences receives FDA fast track designation for belzupacap sarotalocan (AU-011) for the treatment of non-muscle invasive bladder cancer

30 June 2022 - Aura Biosciences today announced that the U.S. FDA has granted fast track designation for belzupacap sarotalocan (AU-011), ...

Read more →

Revlimid maintenance therapy passes reimbursement review

30 June 2022 - Revlimid maintenance therapy to treat multiple myeloma passed the health insurance review agency’s reimbursement review four ...

Read more →